USA: 
Europe: 
Email: 
Consultation
| Catalog: | C0097A |
| Product Type: | Antibody |
| Analysis mode: | WB, IF, ELISA |
| Species specificity: | Human, mouse, rat |
| Host: | Rabbit |
| Clonality: | Polyclonal |
| Isotype: | IgG |
| Concentration: | 170 μg/mL |
| Storage: | -20℃ |
| Buffer: | PBS with 0.1% sodium azide and 50% glycerol pH 7.3 |
| Purification method: | Antigen affinity purification |
| Conjugation: | Unconjugated |
| Immunogen: | ELAC2 |
| Genn_ID: | 60528 |
| Gene accession: | BC004158 |
HPC2 is a potential prostate cancer susceptibility gene, which plays a role in the genetic susceptibility of prostate cancer. It is a zinc phosphodiesterase that shows some tRNA 3'processing endonuclease activity and may be involved in tRNA maturation by removing the 3'-trailer from the tRNA precursor. ELAC2 deficiency may be a cause of prostate cancer susceptibility (PC).
Diagnostic Development
Follow Us -
Copyright © 2025 Creative Biogene. All rights reserved.
